NEW PRODUCT RELEASES


PREVIOUS RELEASES:

No new products available this month.
No new products available this month.


PRODUCT SCOOP

To support the advancement of the next generation of kinase-targeted therapeutic programs, SignalChem has developed over 50 clinically relevant active EGFR mutants, representing the most comprehensive list of this class of proteins in the industry. Epidermal Growth Factor Receptor (EGFR) is an important trans-membrane Receptor Tyrosine Kinase extensively recognized for the role it plays in Cancer. Mutations in the EGFR encoding gene can compromise its biological function resulting in deregulation of key cell-signaling pathways. These alterations are the driving agents in many cancers as non-small cell lung cancer, glioblastoma, and basal-like breast cancer.

Tyrosine kinase inhibitors, targeting critical EGFR mutations have revolutionized targeted therapeutics of multiple key cancers such as non-small cell lung cancer (NSCLC) and has established EGFR's as important drug targets. Furthermore, researchers are constantly being challenged by resistance to EGFR targeting cancer therapies, as a result, altering the clinical implications of these anti-EGFR treatments and drug discovery projects. To tackle these challenges, and aide the global life science community, SignalChem has utilized our protein kinase experts with over 100 years of combined experience in developing an effective line of biologically active recombinant EGFR mutants for the international research community.



Upcoming Events

Come chat with us at the following events:

AACC 2019

Anaheim Convention Center
Anaheim, CA, USA
August 6 - 8, 2019

Discovery on Target

The Westin Copley Place
Boston, MA, USA
September 16 - 19, 2019

BioJapan 2019

Pacifico Yokohama
Japan
October 9 - 11, 2019

Society for Neuroscience 2019

McCormick Place
Chicago, IL, USA
October 19 - 23, 2019

Medica 2019

Messe Dusseldorf
Dusseldorf, Germany
November 18 - 21, 2019

Online Resources

Check out our online resources to help with your research needs.

See All Products

View the comprehensive list of our diverse and high-quality products.

Drug Discovery

Learn more about our kinase focused drug discovery programs.

News Releases

Find the latest news and updates about our company.

Product Related Publications

SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox